Jeevan Scienti, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹23 crore and net profit of ₹2.90 crore for the September 2026 quarter.
Jeevan Scienti. (BSE: JSTL) closed at ₹81.05 on 20 Nov 2026, up 31.0% over the past year. Its market capitalisation is ₹163 crore and it trades at 22.8 times earnings.
Incorporated in 1999, Jeevan Scientific Technology Ltd is an Independent Clinical Contract Research Organization which offers technology-driven clinical research solutions
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.